304 related articles for article (PubMed ID: 16784850)
1. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850
[TBL] [Abstract][Full Text] [Related]
2. Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.
Redelinghuys P; Nchinda AT; Chibale K; Sturrock ED
Biol Chem; 2006 Apr; 387(4):461-6. PubMed ID: 16606345
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme.
Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
[TBL] [Abstract][Full Text] [Related]
5. New ketomethylene inhibitor analogues: synthesis and assessment of structural determinants for N-domain selective inhibition of angiotensin-converting enzyme.
Sharma RK; Douglas RG; Louw S; Chibale K; Sturrock ED
Biol Chem; 2012 May; 393(6):485-93. PubMed ID: 22628311
[TBL] [Abstract][Full Text] [Related]
6. Development of domain-selective angiotensin I-converting enzyme inhibitors.
Redelinghuys P; Nchinda AT; Sturrock ED
Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.
Olimpieri F; Tambaro S; Fustero S; Lazzari P; Sanchez-Roselló M; Pani L; Volonterio A; Zanda M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4715-9. PubMed ID: 19596577
[TBL] [Abstract][Full Text] [Related]
8. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antienzymic activity of two new angiotensin converting enzyme inhibitors.
Dudkiewicz J; Suska T; Tautt J; Paruszewski R
Pol J Pharmacol Pharm; 1991; 43(1):33-8. PubMed ID: 1663247
[TBL] [Abstract][Full Text] [Related]
10. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates.
Bersanetti PA; Andrade MC; Casarini DE; Juliano MA; Nchinda AT; Sturrock ED; Juliano L; Carmona AK
Biochemistry; 2004 Dec; 43(50):15729-36. PubMed ID: 15595828
[TBL] [Abstract][Full Text] [Related]
11. Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors.
Tzakos AG; Gerothanassis IP
Chembiochem; 2005 Jun; 6(6):1089-103. PubMed ID: 15883972
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel triazoles and mannich bases functionalized 1,4-dihydropyridine as angiotensin converting enzyme (ACE) inhibitors.
Kumbhare RM; Kosurkar UB; Bagul PK; Kanwal A; Appalanaidu K; Dadmal TL; Banerjee SK
Bioorg Med Chem; 2014 Nov; 22(21):5824-30. PubMed ID: 25300819
[TBL] [Abstract][Full Text] [Related]
13. Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition.
Ottaviani JI; Actis-Goretta L; Villordo JJ; Fraga CG
Biochimie; 2006; 88(3-4):359-65. PubMed ID: 16330143
[TBL] [Abstract][Full Text] [Related]
14. Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors.
Gomez C; Berteina-Raboin S; De Nanteuil G; Guillaumet G
Bioorg Med Chem; 2013 Nov; 21(22):7216-21. PubMed ID: 24095015
[TBL] [Abstract][Full Text] [Related]
15. Glycosides and amino acyl esters of carbohydrates as potent inhibitors of angiotensin converting enzyme.
Lohith K; Vijayakumar GR; Somashekar BR; Sivakumar R; Divakar S
Eur J Med Chem; 2006 Sep; 41(9):1059-72. PubMed ID: 16730392
[TBL] [Abstract][Full Text] [Related]
16. Effect of varying chain length between P(1) and P(1') position of tripeptidomimics on activity of angiotensin-converting enzyme inhibitors.
Chaudhary S; Vats ID; Chopra M; Biswas P; Pasha S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4364-6. PubMed ID: 19523823
[TBL] [Abstract][Full Text] [Related]
17. An angiotensin-I converting enzyme inhibitor from buckwheat (Fagopyrum esculentum Moench) flour.
Aoyagi Y
Phytochemistry; 2006 Mar; 67(6):618-21. PubMed ID: 16458941
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis of angiotensin converting enzyme inhibitors containing residues of substituted quinolines and a study of their biological activity].
Filatova MP; Krit NA; Uskova NN; Maksimova EM; Gracheva IN; Reĭssmann Z
Bioorg Khim; 1991 May; 17(5):690-6. PubMed ID: 1662954
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.
Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR
J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442
[TBL] [Abstract][Full Text] [Related]
20. Structure-function studies of BPP-BrachyNH
Arcanjo DDR; Vasconcelos AG; Nascimento LA; Mafud AC; Plácido A; Alves MMM; Delerue-Matos C; Bemquerer MP; Vale N; Gomes P; Oliveira EB; Lima FCA; Mascarenhas YP; Carvalho FAA; Simonsen U; Ramos RM; Leite JRSA
Eur J Med Chem; 2017 Oct; 139():401-411. PubMed ID: 28810191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
